DrAlexandra O'Donohue

Dr O'Donohue received her BMedSci(Hons) in molecular biology and genetics in 2018 and then went on to complete her PhD from the University of Sydney in 2023. Throughout her postgraduate studies, she cultivated a keen interest in gene therapy, developing an expertise in the design, generation, and screening of tissue-specific recombinant adeno-associated vectors (rAAVs). She has continued to pursue gene therapy in her postdoctoral fellowship with the goal of preventing tumour formation in individuals born with the cancer predisposition syndrome, Neurofibromatosis type 1/2.